All Comments by John Breitner
Go to another page:
- 1
- 2
- Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
- Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline.
- Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans.
- APOE, vascular pathology, and the AD brain.
- Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
- S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis.
- Merck Withdraws Vioxx®
- Philadelphia: All Is Not Well with the Statin Story
- Philadelphia: All Is Not Well with the Statin Story
- Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.
- Naproxen/Rofecoxib Trial Results Published
- One Thumb Up on Dietary Fat, One Down on Vitamins, Two Down on Estrogen
- Early Clinical Results of Cox 2 Inhibitor: No Pain, No Gain?